An automated spectrophotometric assay for serum a-hydroxybutyrate dehydrogenase (SHBD) activity has been developed. This 
I96I; Elliott, Jepson, and Wilkinson, I962; Konttinen and Halonen, I962; Rosalki, I963; Rosalki and Wilkinson, I964), though raised levels are known to occur in other conditions, mainly diseases of the liver, megaloblastic anaemias, and the muscular dystrophies (Elliott and Wilkinson, I96I, I963; Johnston et al., I966) . But the availability of other serum enzyme tests such as aspartate and alanine aminotransferase (SGOT and SGPT) and ATP: creatine phosphotransferase (CPK) has rendered the position of SHBD controversial; some authors consider that its determination in suspected cases of myocardial infarction is most advantageous (Preston, Batsakis, and Briere, I964; Stuart et al., I965) , while others are of the opinion that it does not contribute more than alternative estimations to diagnostic accuracy in this condition (Nissen, Ranl0v , and WeisFogh, I965; Griffiths, I966; Smith, I967).
In the belief that an automated method for SHBD determination would enable a more rapid and economical throughput of samples, we have devised an ultra-micro automated spectrophotometric procedure for SHBD determination which has many advantages over previous techniques (Schwartz, Kessler, and Bodansky, I96I; Strandjord and Clayson, I966; Dube, Hunter, and Knight, I968) . This report describes its application to a large series of non-hospitalized control subjects, and to patients in whom the possibility of myocardial infarction was raised by the physician. The diagnostic accuracy of SHBD has been compared with that of the aminotransferases in the latter group.
Material and method Apparatus The following items were purchased from Technicon Instruments Co. Ltd., Chertsey, Surrey: proportioning pump module; sampler II module; I20/hr. cam with l:2 sample: wash ratio; glass coil (IO5-II73-I) length I2I9 cm., 2-0 mm. I.D.
The following items were purchased from Beckman Instruments Ltd., Glenrothes, Fifeshire, Scotland: DB spectrophotometer (Cat.
No. SI402H); 5f linear/log recorder (Cat. The absorbance of the substrate solution at 340 nm. is approximately 1-45. The range-expander is set to give a recorder scale of 0-5-I-5.
The system has a range equivalent to SHBD activities of o-6oo mIU/ml. at 25°C. When sera are pumped with substrate solution, the reduction in absorbance at 340 nm. is proportional to SHBD activity, the latter being determined using a calibration curve drawn from the peaks given by the standards. Blank determinations are carried out by pumping sera with buffer and NADH alone, the final NADH concentration being 0-2 mM to give an absorbance at 340 nm. of approximately i-O. The effect of serum is to increase the apparent absorbance of the buffered NADH, and this increment, which in clear sera corresponds to about IO mIU/ml. and in turbid sera to as much as IOO mIU/ml., is converted to SHBD activity from the calibration curve and added to that obtained with the same serum in the presence of substrate solution. The amount of serum sampled is 7.5 ,u. for the test and 7.5 ulI.
for the blank.
Carry-over This was assessed by sampling a serum of low activity before and after a serum of high activity (Fig. 2) . Nine replicates of the high serum gave a mean of 475 mIU/ml. (SD 5-8 mIU/ml.). Five replicates of the low serum when sampled before the high serum gave a mean of ioi mIU/ml. (SD 4 2) and when sampled after the high serum a mean of II7 mIU/ml.
(SD 4-5). The carry-over was thus 3.4 per cent of the high-activity serum. The total number of subjects was thus 648; the distribution with respect to age and sex is given in Fig. 3 . Serum was separated within an hour, divided into aliquots for each subject, and stored at -20°C. Over the next 6 weeks, in addition to SHBD activity in all subjects, the following determinations were carried out on subjects in groups a and b: urea, uric acid, cholesterol, alkaline phosphatase, inorganic phos- (2) Electrocardiogram-positive cases without clinical evidence Despite unequivocal evidence of recent infarction on the tracings, patients lacked the characteristic pain (silent infarct), and investigation was usually prompted by onset of cardiac failure, arrhythmia, hypotension, or embolism. The precise time of infarction could not always be ascertained.
(3) Clinically-positive cases without confirmation on electrocardiogram In these patients, the electrocardiogram gave normal or ambiguous results, often because of previous infarction or the presence of arrhythmia. But the typical clinical features described under (i) above were present, and, despite careful investigation could not be explained on grounds other than infarction.
4) Negative
Electrocardiograms in these patients gave normal or equivocal results. The clinical features were rarely pathognomonic of infarction and, with few exceptions, were adequately explained by a final diagnosis other than that of myocardial infarction.
Results
Normals The mean and SD of SHBD activity for men was I28 ± 35 mIU/ml., and for women i26±33 mIU/ml. The distribution was typically Gaussian, I3 cases lying above 2oo mIU/ml., and I2 below 60 mIU/ ml. This range of 6o-2oo mIU/ml. thus embraced 95 per cent of the population and fulfilled acceptable criteria for a normal range. Though 53 of the 164 subjects in Group C (aged 65 and over) were under treatment for chronic illness, their inclusion had no effect upon the data.
A striking correlation between age and SHBD activity was seen in women (Fig. 3) , the mean value almost doubling between the second and ninth decades (R = o0298; p < o-ooi). In men, the influence of age upon SHBD activity was less apparent (R=0.227; p <o.oo5). An inverse relation between SHBD activity and serum urea concentration was seen in men (R= -0o28i; p<o-ooi), and a direct relation between SHBD activity and serum magnesium concentration in women (R=0o209; p<o-oi). There was no indication whether the former relation was due to chemical inhibition by urea of LDH isoenzymes (Withycombe, Plummer, and Wilkinson, I965; Emery, Moores, and Hodson, I968) or to a dependence of urea concentration and SHBD activity upon renal function. Fig. 4 least 5 days after onset of symptoms. All had normal SGOT activity, but 6 had raised SHBD activity; this confirms the superiority of the latter in detecting late cases of myocardial infarction. Seventeen cases with consistently normal SHBD activity and i6 with consistently normal SGOT activity had at least one sample taken during the I2-to 72-hour period after infarction when maximal enzyme increases are to be expected.
Negative (286 cases) Raised SHBD activity was detected in 67 cases. Haemolysis of the sample accounted for i2 of these, Addisonian anaemia for 2, pericarditis for 3, renal failure for 3, cardiac surgery for 3, non-thoracic major surgery for 4, pulmonary embolism for 3, cardiac arrhythmias for 5, severe angina for 5, congestive cardiac failure for 4, and bronchial carcinoma for i. The remaining 22 suffered from miscellaneous conditions, mainly abdominal, occasionally associated with raised SHBD activity (Elliott and Wilkinson, I963) . Of 62 patients with raised SGOT activity, the ratio of aminotransferase activities (SGPT: SGOT> i) in 25 was suggestive of hepatic disease, and the result could not be In 7, SHBD activity was raised and in 7 it was normal. Two subjects whose infarction occurred more than one week before admission showed raised activity; 2 other subjects in this category had normal activity. SGOT activity was normal in 8 cases and raised in 6, but in 3 of the latter the SGPT: SGOT ratio was greater than unity and all had congestive heart failure; on this basis alone, infarction would not therefore have been suspected. All 4 cases admitted later than one week from the date of infarction gave normal values for SGOT.
Clinically-positive cases without confirmation on electrocardiogram (31 cases) In 23, SHBD activity was raised and in 8 it was normal: the latter included one case examined for the first time I6 days after suspected infarction and one case dying within 8 hours of onset of symptoms. SGOT activity was normal in 7 cases and raised in 24, but in 2 of the latter the SGPT: SGOT ratio was greater than unity; aminotransferase determinations in these patients thus did not provide unequivocal support for the clinical diagnosis. Crowley (I967) . Our experience accords with that of Amador et al. (I966) . Before undertaking the present work, we surveyed a series of patients classified according to the criteria already outlined in whom 4 consecutive aminotransferase determinations spanning the period of 8-72 hours after onset of symptoms were carried out by a colori-metric technique (King, I958 
